article thumbnail

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Pharmacy Times

November 21, 2019. Effect of acalabrutinib in combination with bendamustine plus rituximab on survival endpoints in older patients with mantle cell lymphoma: insights from the ECHO trial. healthbook TIMES Onco Hema. 2024;22(4):22-29. doi:10.36000/HBT.OH.2024.22.163 ClinicalTrials.gov. Updated February 19, 2025. Accessed May 14, 2025.

article thumbnail

Under the Weather: Unpacking the Impact of the 2024-2025 Influenza Season

Pharmacy Times

million fewer doses were administered in retail and clinical settings than in the prepandemic 2019-2020 season. Additionally, vaccination rates among Medicare beneficiaries 65 years and older reached only 48.3%, and nearly 9.2

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharmacists Push Forward: Innovative Clinical Solutions Highlighted at McKesson ideaShare 2025

Pharmacy Times

Within the pharmacy, the average appointment time for contraception prescribing is just 20 minutes, and Meredith highlighted the importance of involving pharmacy technicians to streamline the workflow. May 9, 2019. Waiting for an appointment with an OB-GYN can take weeks to months. Presented at: McKesson ideaShare 2025.

article thumbnail

Hypertension: A Silent Killer Requiring Novel Therapies

Pharmacy Times

Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants Lancet 2021 Sep 11;398(10304):957-980. Current Cardiology Reports 2019; 21. Jansen, PharmD Candidate , Mark A. High Blood Pressure Facts.

article thumbnail

Secondary Analysis Investigates Spillover Effects of Antibiotic Audit and Feedback

Pharmacy Times

million deaths in 2019 alone. This post hoc secondary analysis, published by investigators in JAMA Network , aims to determine if this intervention had a spillover effect on antibiotic prescribing across the entire patient population. 1 Image credit: I Viewfinder | stock.adobe.com According to WHO, AMR accounted for 1.27

article thumbnail

Avatrombopag Receives FDA Approval for Treamtent of Pediatric Patients With Chronic Immune Thrompcytopenia

Pharmacy Times

In 2019, the FDA approved avatrombopag’s expanded indication for treatment of adults with chronic immune thrombocytopenia (ITP) that hasn't responded satisfactorily to a previous therapy. June 27, 2019. It was initially approved in 2018 for thrombocytopenia in adults with chronic liver disease scheduled to undergo a procedure.

article thumbnail

Pharmacists Have a Crucial Role Helping Patients With ATTR-CM Navigate Treatment With Tafamidis

Pharmacy Times

1,2 Tafamidis in the Treatment of ATTR-CM Initially approved in 2019 3 , tafamidis (Vyndamax; Pfizer) is a selective transthyretin (TTR) kinetic stabilizer that binds to thyroxine-binding sites on TTR tetramers, which prevents dissociation into monomers, or the breakdown into amyloid deposits that damage the heart in ATTR-CM. May 6, 2019.